David Klenerman

Last updated

Sir

David Klenerman

FRS FMedSci
BornSeptember 1959 (age 64) [1]
NationalityBritish
Alma mater University of Cambridge (MA, PhD)
Known for Illumina dye sequencing
Scanning ion-conductance microscopy
Super-resolution microscopy
Solexa
Children2 (Laura & Anna)
Awards
Scientific career
Fields Biophysical chemistry
Institutions University of Cambridge
Stanford University
Thesis Infrared chemiluminescence using a SISAM spectrometer  (1985)
Doctoral advisor Ian William Murison Smith
Other academic advisors Richard Zare
Website klenermangroup.co.uk

Sir David Klenerman FRS FMedSci [3] [4] (born 1959) is a British biophysical chemist and a professor of biophysical chemistry at the Department of Chemistry at the University of Cambridge [5] and a Fellow of Christ's College, Cambridge. [6]

Contents

He is best known for his contribution in the field of next-generation sequencing of DNA (that subsequently resulted in Solexa, a high-speed DNA sequencing company that he co-founded), [1] [7] [8] [9] [10] nanopipette-based scanning ion-conductance microscopy, [11] [12] and super-resolution microscopy. [13]

Early life and education

Klenerman is the son of two South African-born Jews. [14] He was educated at the University of Cambridge where he was an undergraduate student of Christ's College, Cambridge and received his BA degree in 1982. [15] He earned his PhD degree in chemistry in 1986 as a postgraduate student of Churchill College, Cambridge and was supervised by Ian William Murison Smith. [16] [2] [15]

Career and research

After his doctorate, Klenerman went to Stanford University as a Fulbright scholar to work on high-overtone chemistry, with Richard Zare. After his postdoctoral research at Stanford, he returned to United Kingdom to work in BP Research for seven years. Then, in 1994, he joined the University of Cambridge, as a faculty member of the Department of Chemistry and a fellow of Christ's College. [2] [15] [17]

Klenerman, along with Shankar Balasubramanian, invented a method of next-generation DNA sequencing which is commonly known today as the Solexa sequencing or Illumina dye sequencing. [7] [9] The method is based on the detection of fluorophore labelled nucleotides as they get incorporated in the DNA strands. [18] This sequencing by synthesis method gained popularity, [19] [20] and is currently regarded as the most widely used platform to replace conventional Sanger sequencing technique, despite its comparatively low multiplexing capability of samples, as it offers several key advantages: it is automated, quick, highly accurate, capable of sequencing multiple strands simultaneously via massive parallel sequencing, and economically cheaper in case of whole genome sequencing. [21] [22] [23]

He is also known for exploring nanopipette-based (instead of conventional micropipette-based) scanning ion-conductance microscopy methods. [11] [24] His research group was successful in achieving very high resolution topographic images of live-cells, in hopping mode imaging, in precise delivery of small molecules to cell, and in studying real time detailed cell-functioning. [12] [25] [26]

Most recently, his group is focusing on 3D super-resolution microscopy to develop new insights on protein misfolding and neurodegenerative diseases. [13]

Commercial activities

Klenerman and Shankar Balasubramanian commercialised their invention on the single-molecule-fluorescence based high-speed DNA sequencing and jointly founded Solexa in 1998. Later, in 2007, this company was acquired by Illumina for $600 million. [7] [27] [28] [29] [30]

In 2004, Klenerman co-founded another spin-out company, Ionscope, to supply assembled scanning ion-conductance microscopes to the research community that looks for high-resolution 3D images of live cells. As per the Biotechnology and Biological Sciences Research Council, as of February 2014, Ionscope sold 35 SICM units worldwide. [31]

Awards and honours

The major awards and honours that Klenerman received in recognition of his research work:

Related Research Articles

<span class="mw-page-title-main">DNA sequencer</span> A scientific instrument used to automate the DNA sequencing process

A DNA sequencer is a scientific instrument used to automate the DNA sequencing process. Given a sample of DNA, a DNA sequencer is used to determine the order of the four bases: G (guanine), C (cytosine), A (adenine) and T (thymine). This is then reported as a text string, called a read. Some DNA sequencers can be also considered optical instruments as they analyze light signals originating from fluorochromes attached to nucleotides.

<span class="mw-page-title-main">DNA sequencing</span> Process of determining the nucleic acid sequence

DNA sequencing is the process of determining the nucleic acid sequence – the order of nucleotides in DNA. It includes any method or technology that is used to determine the order of the four bases: adenine, guanine, cytosine, and thymine. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.

<span class="mw-page-title-main">Chris Abell</span> British biological chemist (1957–2020)

Christopher Abell was a British biological chemist who was a professor of biological chemistry at the Yusuf Hamied Department of Chemistry and Todd-Hamied Fellow of Christ's College, Cambridge. On his 2016 election to the Royal Society, Abell's research was described as having "changed the face of drug discovery."

The Association of Biomolecular Resource Facilities (ABRF) is dedicated to advancing core and research biotechnology laboratories through research, communication, and education. ABRF members include over 2000 scientists representing 340 different core laboratories in 41 countries, including those in industry, government, academic and research institutions.

<span class="mw-page-title-main">Richard Henderson (biologist)</span> British biologist

Richard Henderson is a British molecular biologist and biophysicist and pioneer in the field of electron microscopy of biological molecules. Henderson shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Joachim Frank."Thanks to his work, we can look at individual atoms of living nature, thanks to cryo-electron microscopes we can see details without destroying samples, and for this he won the Nobel Prize in Chemistry."

<span class="mw-page-title-main">Scanning ion-conductance microscopy</span> Scanning probe microscopy technique that uses an electrode as the probe tip

Scanning ion-conductance microscopy (SICM) is a scanning probe microscopy technique that uses an electrode as the probe tip. SICM allows for the determination of the surface topography of micrometer and even nanometer-range structures in aqueous media conducting electrolytes. The samples can be hard or soft, are generally non-conducting, and the non-destructive nature of the measurement allows for the observation of living tissues and cells, and biological samples in general.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.

<span class="mw-page-title-main">ABI Solid Sequencing</span>

SOLiD (Sequencing by Oligonucleotide Ligation and Detection) is a next-generation DNA sequencing technology developed by Life Technologies and has been commercially available since 2006. This next generation technology generates 108 - 109 small sequence reads at one time. It uses 2 base encoding to decode the raw data generated by the sequencing platform into sequence data.

<span class="mw-page-title-main">Whole genome sequencing</span> Determining nearly the entirety of the DNA sequence of an organisms genome at a single time

Whole genome sequencing (WGS), also known as full genome sequencing, complete genome sequencing, or entire genome sequencing, is the process of determining the entirety, or nearly the entirety, of the DNA sequence of an organism's genome at a single time. This entails sequencing all of an organism's chromosomal DNA as well as DNA contained in the mitochondria and, for plants, in the chloroplast.

Methylated DNA immunoprecipitation is a large-scale purification technique in molecular biology that is used to enrich for methylated DNA sequences. It consists of isolating methylated DNA fragments via an antibody raised against 5-methylcytosine (5mC). This technique was first described by Weber M. et al. in 2005 and has helped pave the way for viable methylome-level assessment efforts, as the purified fraction of methylated DNA can be input to high-throughput DNA detection methods such as high-resolution DNA microarrays (MeDIP-chip) or next-generation sequencing (MeDIP-seq). Nonetheless, understanding of the methylome remains rudimentary; its study is complicated by the fact that, like other epigenetic properties, patterns vary from cell-type to cell-type.

Cap analysis of gene expression (CAGE) is a gene expression technique used in molecular biology to produce a snapshot of the 5′ end of the messenger RNA population in a biological sample. The small fragments from the very beginnings of mRNAs are extracted, reverse-transcribed to cDNA, PCR amplified and sequenced. CAGE was first published by Hayashizaki, Carninci and co-workers in 2003. CAGE has been extensively used within the FANTOM research projects.

<span class="mw-page-title-main">Transmission electron microscopy DNA sequencing</span> Single-molecule sequencing technology

Transmission electron microscopy DNA sequencing is a single-molecule sequencing technology that uses transmission electron microscopy techniques. The method was conceived and developed in the 1960s and 70s, but lost favor when the extent of damage to the sample was recognized.

Manteia Predictive Medicine S.A. was a start-up company created in November 2000 as a spin-off of Serono, a Swiss-based biotechnology company, now part of Merck-Serono, by private founders. Its aim was to provide preventive and curative treatment guidelines for common and complex diseases. These guidelines were envisaged as composed of two parts:

Massive parallel sequencing or massively parallel sequencing is any of several high-throughput approaches to DNA sequencing using the concept of massively parallel processing; it is also called next-generation sequencing (NGS) or second-generation sequencing. Some of these technologies emerged between 1993 and 1998 and have been commercially available since 2005. These technologies use miniaturized and parallelized platforms for sequencing of 1 million to 43 billion short reads per instrument run.

<span class="mw-page-title-main">$1,000 genome</span> Era of predictive and personalized medicine

The $1,000 genome refers to an era of predictive and personalized medicine during which the cost of fully sequencing an individual's genome (WGS) is roughly one thousand USD. It is also the title of a book by British science writer and founding editor of Nature Genetics, Kevin Davies. By late 2015, the cost to generate a high-quality "draft" whole human genome sequence was just below $1,500.

<span class="mw-page-title-main">Illumina dye sequencing</span> DNA sequencing method

Illumina dye sequencing is a technique used to determine the series of base pairs in DNA, also known as DNA sequencing. The reversible terminated chemistry concept was invented by Bruno Canard and Simon Sarfati at the Pasteur Institute in Paris. It was developed by Shankar Balasubramanian and David Klenerman of Cambridge University, who subsequently founded Solexa, a company later acquired by Illumina. This sequencing method is based on reversible dye-terminators that enable the identification of single nucleotides as they are washed over DNA strands. It can also be used for whole-genome and region sequencing, transcriptome analysis, metagenomics, small RNA discovery, methylation profiling, and genome-wide protein-nucleic acid interaction analysis.

<span class="mw-page-title-main">Shankar Balasubramanian</span> Indian-born British chemist

Sir Shankar Balasubramanian is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and biomodal.

Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products for the direct, electronic analysis of single molecules.

David Wilson Deamer is an American biologist and Research Professor of Biomolecular Engineering at the University of California, Santa Cruz. Deamer has made significant contributions to the field of membrane biophysics. His work led to a novel method of DNA sequencing and a more complete understanding of the role of membranes in the origin of life.

<span class="mw-page-title-main">Gerardo Turcatti</span> Swiss-Uruguayan chemical biologist and pharmacologist

Gerardo Turcatti is a Swiss-Uruguayan chemist who specialises in chemical biology and drug discovery. He is a professor at the École Polytechnique Fédérale de Lausanne (EPFL) and director of the Biomolecular Screening Facility at the School of Life Sciences there.

References

  1. 1 2 "David KLENERMAN - Personal Appointments (free information from Companies House)". beta.companieshouse.gov.uk.
  2. 1 2 3 4 "Interdisciplinary Award 2007 Winner". Royal Society of Chemistry . Retrieved 26 January 2016.
  3. 1 2 "David Klenerman: Royal Society". Fellows Directory. Royal Society . Retrieved 26 January 2016.
  4. 1 2 "Fellow: Academy of Medical Sciences". Academy of Medical Sciences, United Kingdom. Archived from the original on 26 August 2017. Retrieved 26 January 2016.
  5. ↑ "Professor David Klenerman FMedSci FRS". Department of Chemistry, University of Cambridge. University of Cambridge . Retrieved 26 January 2016.
  6. ↑ "Professor David Klenerman". Christ's College, Cambridge . Retrieved 26 January 2016.
  7. 1 2 3 "History of Illumina Sequencing". Illumina . Retrieved 26 January 2016.
  8. ↑ Davies, Kevin (7 September 2010). The $1,000 Genome . Free Press. pp.  102–115. ISBN   978-1416569596 . Retrieved 26 January 2016.
  9. 1 2 Bentley, DR; Balasubramanian, S; Swerdlow, HP; et al. (6 November 2008). "Accurate whole human genome sequencing using reversible terminator chemistry". Nature . 456 (7218): 53–59. Bibcode:2008Natur.456...53B. doi:10.1038/nature07517. PMC   2581791 . PMID   18987734.
  10. ↑ "The Solexa Story". Bio-IT World. No. September–October 2010. 28 September 2010. Archived from the original on 20 February 2016. Retrieved 26 January 2016.
  11. 1 2 "Nanodoodling shows pipette power". BBC News . 5 September 2006. Retrieved 26 January 2016.
  12. 1 2 "Drawing With DNA: Nanopipette allows voltage-controlled delivery of biomolecules to a surface". Chemical & Engineering News . Vol. 83, no. 44. American Chemical Society. 31 October 2005. Retrieved 26 January 2016.
  13. 1 2 Hell, Stefan W.; Sahl, Steffen J.; Bates, Mark; Zhuang, Xiaowei; Heintzmann, Rainer; Booth, Martin J.; Bewersdorf, Joerg; Shtengel, Gleb; Hess, Harald; Tinnefeld, Philip; Honigmann, Alf; Jakobs, Stefan; Testa, Ilaria; Cognet, Laurent; Lounis, Brahim; Ewers, Helge; Davis, Simon J.; Eggeling, Christian; Klenerman, David; Willig, Katrin I.; Vicidomini, Giuseppe; Castello, Marco; Diaspro, Alberto; Cordes, Thorben; Steffen J. Sahl; Tinnefeld, Philip; Klenerman, David; Katrin I. Willig (14 October 2015). "The 2015 super-resolution microscopy roadmap". Journal of Physics D . 48 (44): 443001. arXiv: 1711.04999 . Bibcode:2015JPhD...48R3001H. doi:10.1088/0022-3727/48/44/443001. S2CID   4804015.
  14. ↑ Frazer, Jenni (28 December 2018). "Seven Holocaust survivors on New Year's Honours List". Jewish News . Retrieved 14 February 2024.
  15. 1 2 3 Anon (2017). "Klenerman, Prof. David" . Who's Who (online Oxford University Press  ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.266724.(Subscription or UK public library membership required.)
  16. ↑ Klenerman, David (1985). Infrared chemiluminescence using a SISAM spectrometer. lib.cam.ac.uk (PhD thesis). University of Cambridge. OCLC   499899771. EThOS   uk.bl.ethos.355881.
  17. ↑ "David Klenerman elected FRS". Christ's College, Cambridge. Archived from the original on 25 August 2017. Retrieved 27 January 2016.
  18. ↑ Balasubramanian, Shankar (4 May 2011). "Sequencing nucleic acids: from chemistry to medicine". Chemical Communications . 47 (26): 7281–7286. doi:10.1039/c1cc11078k. PMC   3428630 . PMID   21544287.
  19. ↑ Quail, Michael A (25 November 2008). "A large genome center's improvements to the Illumina sequencing system". Nature Methods . 5 (12): 1005–1010. doi:10.1038/nmeth.1270. PMC   2610436 . PMID   19034268.
  20. ↑ Cronn, Richard (27 August 2008). "Multiplex sequencing of plant chloroplast genomes using Solexa sequencing-by-synthesis technology". Nucleic Acids Research . 36 (19): e122. doi:10.1093/nar/gkn502. PMC   2577356 . PMID   18753151.
  21. ↑ Metzker, Michael L. (8 December 2009). "Sequencing technologies – the next generation". Nature Reviews Genetics . 11 (1): 31–46. CiteSeerX   10.1.1.719.3885 . doi:10.1038/nrg2626. PMID   19997069. S2CID   205484500.
  22. ↑ Pettersson, Erik; Lundeberg, Joakim; Ahmadian, Afshin (2009). "Generations of sequencing technologies". Genomics . 93 (2): 105–111. doi:10.1016/j.ygeno.2008.10.003. PMID   18992322.
  23. ↑ Quail, Michael A (24 July 2012). "A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers". BMC Genomics . 13 (341): 341. doi: 10.1186/1471-2164-13-341 . PMC   3431227 . PMID   22827831.
  24. ↑ Shevchuk, Andrew I (2011). "Realizing the biological and biomedical potential of nanoscale imaging using a pipette probe". Nanomedicine . 6 (3): 565–575. doi:10.2217/nnm.10.154. PMID   21542692.
  25. ↑ Chen, Chiao-Chen; Zhou, Yi; Baker, Lane A. (2012). "Scanning Ion Conductance Microscopy". Annual Review of Analytical Chemistry . 5 (207): 207–228. Bibcode:2012ARAC....5..207C. doi:10.1146/annurev-anchem-062011-143203. PMID   22524219.
  26. ↑ Bergner, Stefan; Vatsyayan, Preety; Matysik, Frank-Michael (2 May 2013). "Recent advances in high resolution scanning electrochemical microscopy of living cells – A review". Analytica Chimica Acta . 775: 1–13. Bibcode:2013AcAC..775....1B. doi:10.1016/j.aca.2012.12.042. PMID   23601970.
  27. ↑ "Cutting the UK science budget would be a false economy". Financial Times . The Nikkei. 18 June 2013. Retrieved 27 January 2016.
  28. ↑ "$600m for DNA firm". Varsity . Retrieved 27 January 2016.
  29. ↑ "Illumina Buys Solexa". Forbes . 13 November 2006. Retrieved 27 January 2016.
  30. ↑ "Illumina to Buy Solexa For $600 Million in Stock". The Wall Street Journal . 13 November 2006. Retrieved 27 January 2016.
  31. ↑ "New microscope technology enables imaging of live cells". BBSRC . Retrieved 30 January 2016.
  32. ↑ "British Biophysical Society Lecture Tour". University College Dublin . Retrieved 27 January 2016.
  33. ↑ Royal Medal 2018, Royal society.org. Accessed 30 January 2023.
  34. ↑ "2019 New Year Honours List" (PDF). gov.uk. 31 December 2018.
  35. ↑ "Breakthrough Prize – Winners Of The 2022 Breakthrough Prizes In Life Sciences, Fundamental Physics And Mathematics Announced". breakthroughprize.org. Retrieved 13 October 2021.
  36. ↑ Canada Gairdner International Award 2024
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.